Searched over 200M research papers
2 papers analyzed
These studies suggest that while certain enzymes from bacteria may be used in pharmaceutical production involving alcohols, exposure to alcohol during pregnancy can cause developmental issues related to fetal alcohol syndrome.
19 papers analyzed
Crestor, known generically as rosuvastatin calcium, is a statin medication used to lower cholesterol and triglycerides in the blood. It works by inhibiting an enzyme involved in the production of cholesterol in the liver, thereby reducing the risk of cardiovascular disease.
A key component in the synthesis of Crestor is t-butyl 6-chloro-(3R,5S)-dihydroxyhexanoate, a chiral intermediate. This compound can be efficiently produced using a novel alcohol dehydrogenase enzyme discovered from Klebsiella oxytoca. This enzyme, named KleADH, has been shown to convert t-butyl 6-chloro-(5S)-hydroxy-3-oxohexanoate to the desired chiral intermediate with high diastereomeric excess and conversion rates. The enzyme's activity is influenced by factors such as temperature, pH, and the presence of metal ions, with optimal activity observed at 30°C and pH 7.0. Additionally, biphasic systems like n-hexane/water can enhance the enzyme's performance.
Alcohol consumption during pregnancy can lead to fetal alcohol syndrome (FAS), characterized by growth retardation, craniofacial malformations, and neural defects. Research using a chick embryo model has shown that ethanol exposure can lead to increased cell death and reduced numbers of neural crest cells, which are crucial for proper craniofacial and neural development. This cell death is particularly pronounced in the hindbrain and craniofacial mesenchyme, leading to the characteristic features of FAS.
While the direct interaction between Crestor and alcohol is not extensively covered in the provided research, it is important to consider the broader implications of alcohol consumption on health, especially in individuals taking medications like Crestor. Alcohol can affect liver function, which is critical for the metabolism of statins. Impaired liver function can lead to increased levels of the medication in the blood, potentially increasing the risk of side effects such as muscle pain or liver damage.
In summary, Crestor is a statin medication synthesized using a novel alcohol dehydrogenase enzyme, which plays a crucial role in producing its chiral intermediate. Alcohol consumption, particularly during pregnancy, can have severe teratogenic effects, leading to conditions like fetal alcohol syndrome. While the direct interaction between Crestor and alcohol is not detailed in the provided research, it is advisable for individuals on statin therapy to limit alcohol intake to avoid potential liver complications and ensure the medication's efficacy.
Most relevant research papers on this topic